Axil Bio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Axil Bio
Largest movements
- Cash -€38,773
down €38,773 (-52.3%), from €74,188 to €35,415
mainly Other debts (-€33,133) and Current portion of long-term debt (-€30,000)
- Receivables within one year -€9,206
down €9,206 (-22.3%), from €41,278 to €32,072
of which Trade receivables: -€9,221
- Stocks and contracts -€4,768
down €4,768 (-4.4%), from €107,360 to €102,592
- Tangible fixed assets -€3,607
down €3,607 (-43.4%), from €8,311 to €4,704
- Other debts -€33,133
down €33,133 (-52.5%), from €63,133 to €30,000
- Current portion of long-term debt -€30,000
no longer reported in 2025 (was €30,000)
- Reserves +€7,603
up €7,603 (+7.5%), from €101,477 to €109,080
- Write-downs -€84,015
down €84,015, from €12,405 to -€71,610
- Financial charges +€75,939
up €75,939 (+2,192%), from €3,465 to €79,404
- Gross operating margin -€6,710
down €6,710 (-23.9%), from €28,058 to €21,348
- Financial income -€1,321
down €1,321 (-96.4%), from €1,371 to €50
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €233,275 | €176,882 | -€56,394 | -24.2% |
| Fixed assets | 21/28 | €8,311 | €4,704 | -€3,607 | -43.4% |
| Tangible fixed assets | 22/27 | €8,311 | €4,704 | -€3,607 | -43.4% |
| Plant, machinery and equipment | 23 | €8,311 | €4,704 | -€3,607 | -43.4% |
| Current assets | 29/58 | €224,964 | €172,178 | -€52,786 | -23.5% |
| Stocks and contracts in progress | 3 | €107,360 | €102,592 | -€4,768 | -4.4% |
| Stocks | 30/36 | €107,360 | €102,592 | -€4,768 | -4.4% |
| Amounts receivable within one year | 40/41 | €41,278 | €32,072 | -€9,206 | -22.3% |
| Trade receivables | 40 | €38,988 | €29,767 | -€9,221 | -23.7% |
| Other amounts receivable | 41 | €2,290 | €2,305 | +€15 | +0.6% |
| Cash at bank and in hand | 54/58 | €74,188 | €35,415 | -€38,773 | -52.3% |
| Deferred charges and accrued income | 490/1 | €2,138 | €2,099 | -€39 | -1.8% |
| Total equity and liabilities | 10/49 | €233,275 | €176,882 | -€56,394 | -24.2% |
| Equity | 10/15 | €131,977 | €139,580 | +€7,603 | +5.8% |
| Contributions | 10/11 | €30,500 | €30,500 | = | 0.0% |
| Reserves | 13 | €101,477 | €109,080 | +€7,603 | +7.5% |
| Distributable reserves | 133 | €101,477 | €109,080 | +€7,603 | +7.5% |
| Amounts payable | 17/49 | €101,298 | €37,302 | -€63,996 | -63.2% |
| Amounts payable within one year | 42/48 | €99,523 | €35,232 | -€64,291 | -64.6% |
| Current portion of amounts payable after more than one year | 42 | €30,000 | - | -€30,000 | |
| Trade debts | 44 | €4,000 | €1,806 | -€2,193 | -54.8% |
| Suppliers | 440/4 | €4,000 | €1,806 | -€2,193 | -54.8% |
| Taxes, remuneration and social security | 45 | €2,390 | €3,426 | +€1,035 | +43.3% |
| Taxes | 450/3 | €2,390 | €3,426 | +€1,035 | +43.3% |
| Other amounts payable | 47/48 | €63,133 | €30,000 | -€33,133 | -52.5% |
| Accrued charges and deferred income | 492/3 | €1,775 | €2,069 | +€294 | +16.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,656 | €3,607 | -€49 | -1.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €12,405 | -€71,610 | -€84,015 | |
| Other operating charges | 640/8 | €2,155 | €2,395 | +€239 | +11.1% |
| Gross operating margin | 9900 | €28,058 | €21,348 | -€6,710 | -23.9% |
| Operating profit (loss) | 9901 | €9,842 | €86,957 | +€77,115 | +784% |
| Financial income | 75/76B | €1,371 | €50 | -€1,321 | -96.4% |
| Recurring financial income | 75 | €1,371 | €50 | -€1,321 | -96.4% |
| Financial charges | 65/66B | €3,465 | €79,404 | +€75,939 | +2,192% |
| Recurring financial charges | 65 | €3,465 | €79,404 | +€75,939 | +2,192% |
| Profit (loss) for the period before taxes | 9903 | €7,747 | €7,603 | -€145 | -1.9% |
| Income taxes | 67/77 | €0 | €0 | -€0 | -40.9% |
| Profit (loss) for the period | 9904 | €7,747 | €7,603 | -€145 | -1.9% |
| Profit (loss) for the period to be appropriated | 9905 | €7,747 | €7,603 | -€145 | -1.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.